You are here: Industry Insights > Avacta

News List

Avacta Collaborates with Liverpool School of Tropical Medicine contractpharma
August 11, 2020
Will clinically validate the coronavirus antigen test that Avacta is developing with Cytiva.
Avacta Partners with BBI Solutions contractpharma
August 10, 2020
BBI will manufacture the rapid SARS-CoV-2 antigen test that is being developed.
Avacta, Daewoong Expand Affimer Alliance contractpharma
July 31, 2020
To develop stem cell therapies for COVID-19 and future pandemic diseases.
Avacta, Cytiva Collaborating on COVID-19 Rapid Test americanpharmaceuticalreview
April 13, 2020
Avacta Group has entered into a collaboration with Cytiva, formerly known as GE Healthcare Life Sciences.
Avacta and Cytiva team up for COVID-19 pharmatimes
April 10, 2020
Avacta and Cytiva (formerly known as GE Healthcare Life Sciences) have formed a collaboration to develop and manufacture an Affimer-based point-of-care rapid test intended.
Avacta, LG Chem Life Sciences Agree Multi-Target Affimer Therapeutics Development Alliance americanpharmaceuticalreview
December 17, 2018
Avacta and LG Chem Life Sciences announced a multi-target collaboration and development agreement. The agreement provides LG Chem with .....
Avacta, LG Chem Life Sciences to develop novel drugs for cancer, inflammation biospectrumasia
December 17, 2018
As per the deal, LG Chem and Avacta will collaborate to progress these candidates through to drug candidate selection and LG Chem will be responsible for preclinical and clinical development and world-wide
Avacta, Glythera link to develop drug conjugates pharmatimes
January 17, 2018
UK companies Avacta and Glythera have sealed a licensing deal to develop drug conjugates using their combined technologies.

Previous page 1 2 Next page